Navigation Links
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Date:9/12/2013

weighing <40 kg, or in INSTI-experienced paediatric patients with documented or clinically suspected INSTI resistance.

Please visit the following link for the full U.S. prescribing and patient information: https://www.viivhealthcare.com/media/58599/us_tivicay.pdf

About FLAMINGO (ING114915)
FLAMINGO is an ongoing phase IIIb/IV, randomised, multi-centre, multinational, open-label non-inferiority (-12% margin) study with a pre-specified test for superiority, designed to compare the efficacy and safety of dolutegravir to darunavir regimens in HIV-1 infected, treatment-naive patients. The primary objective for FLAMINGO is to demonstrate the antiviral activity of a dolutegravir regimen compared to a darunavir regimen over 48 weeks. As per study design, trial participants will continue on therapy in order to assess the tolerability, long-term safety, and antiviral and immunologic activity of dolutegravir vs darunavir over 96 weeks. Investigators will also evaluate viral resistance in patients experiencing virologic failure.

About Tivicay® (dolutegravir)
Tivicay is an integrase inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 in adults and children aged 12 years and older weighing at least 40 kg. Integrase inhibitors block HIV replication by preventing the viral DNA from integrating into the genetic material of human immune cells (T-cells). This step is essential in the HIV replication cycle and is also responsible for establishing chronic infection.

It is available as a small, yellow, 50mg tablet. Importantly, it can be taken with or without food and at any time of the day.

ViiV Healthcare announced submission of a Marketing Authorisation Application (MAA) for dolutegravir to the European Medicines Agency (EMA) on 17 December 2012. Regulatory applications are also being evaluated i
'/>"/>

SOURCE ViiV Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... from the U.S. Food and Drug Administration (FDA) of ... Oral Solution 5mg/5mL. Trailing twelve-month sales for the product ... competitors. ANI expects to begin shipping to its customers ... and CEO of ANI Pharmaceuticals, stated, "This ANDA represents ...
(Date:6/2/2015)... 2, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... studies performed with ORMD-0801, its orally ingestible insulin capsule ... the poster sessions in the ADA 75 th ... Boston . The poster will be attended by ...
(Date:6/2/2015)... 2, 2015  CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached an agreement to ... Delaware Court of Chancery, which names ... former directors and officers, and names the Company as ... In re CytRx Corp. Stockholder Derivative Litigation , C.A. ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE—News) ("Ampio" or the ... uses for previously approved drugs and new molecular ... agreement to acquire certain rights relating to a ... that can be used worldwide to elevate the ...
... Nearly one million doses of the NOBIVAC Canine ... shelters and rescue groups in 49 states as part ... between the Petfinder.com Foundation and Merck Animal Health.   The ... the canine influenza virus (CIV), better known as dog ...
Cached Medicine Technology:Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology 2Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology 3Nearly 1,400 Animal Shelters and Rescues, in Partnership With Veterinarians, Build Community Immunity Against Canine Influenza 2
(Date:6/2/2015)... June 02, 2015 National Autism Resource ... marketing, web design and development agency, to launch its ... National Autism Resources’ new website is designed ... all ages diagnosed with autism. The site will expand ... an array of resources, from easy to understand information ...
(Date:6/2/2015)... LUSAKA, Zambia (PRWEB) June 02, 2015 ... agricultural businesses, today opened a new seed warehouse and ... capacity and meet farmer demand for both local and ... Africa. , “Zambia could emerge as the breadbasket ... fostered,” said Worede Woldemariam, East and South Central Africa ...
(Date:6/2/2015)... 2015 ODU , a ... connector solutions and cable assemblies, is announcing its ... the US market. , ODU MINI-SNAP® ... The self- securing circular connector solution is ideal ... require significant customization such as: sensor devices, data ...
(Date:6/2/2015)... PhishLine, LLC today announced it will ... Suite 125 in Waukesha, Wisconsin 53186. The ... of operations for PhishLine’s current corporate staff and ... Mark Chapman, Founder and President, commented “PhishLine is ... customers adopt our market leading service to address ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The ... for non-GMO products made according to rigorous best ... products are produced in compliance with the Non-GMO ... all GMO risk ingredients, facility inspections and an ... for GMO avoidance. , “Savoury Systems is and ...
Breaking Medicine News(10 mins):Health News:National Autism Resources Launches New Website, Delivering More Products and Services 2Health News:National Autism Resources Launches New Website, Delivering More Products and Services 3Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:PhishLine, LLC Announces New Corporate Headquarters 2Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2
... Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) and Autoliv ... Inc. (NYSE: ALV and SSE: ALIV),today ... supply,agreement for chemical heat packages, a key component ... easy to use single-dose,Staccato devices each contain a ...
... Behaviors Found in Boys, Not Girls, SEATTLE, Nov. ... 2 and 5 years of age is clearly linked ... age 7 to 9,according to a new study published ... Christakis, MD, MPH, and Frederick,Zimmerman, PhD, both of Seattle ...
... asthma among young inner-city children appears to be more unpredictable ... is a wise move as a hedge against dangerous flare-ups ... a study from the Johns Hopkins Childrens Center. Current asthma ... diagnosis, but six months may be too long for many ...
... explain why the supposedly natural act of aging is by ... , In a study to be presented Nov. ... in Orlando, Fla., the Hopkins team analyzed more than a ... minute changes in the hearts of 5,004 men and women, ...
... Doctors need to do more to erase racial disparities, study ... high blood pressure among heart failure patients vary widely by ... team at the Medical University of South Carolina, Mt. Pleasant, ... failure patients, but experts know little about actual rates of ...
... including one from the Framingham Heart Study,link PAT signal with ... ... Fla., Nov. 4 Itamar Medical announced,confirmation of PAT technology ... PAT technology, Itamar Medical will now,promote clinical use in the ...
Cached Medicine News:Health News:Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System 2Health News:Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System 3Health News:Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System 4Health News:Watching Violent TV at Pre-School Age Linked to Aggression in Young Boys 2Health News:Watching Violent TV at Pre-School Age Linked to Aggression in Young Boys 3Health News:Watching Violent TV at Pre-School Age Linked to Aggression in Young Boys 4Health News:Urban kids with asthma need more frequent check-ups, Hopkins study suggests 2Health News:Aging heart changes shape, shrinks and loses pumping function too 2Health News:Aging heart changes shape, shrinks and loses pumping function too 3Health News:Poorer Blood Pressure Control in Blacks With Heart Failure 2Health News:New Research Released at AHA Confirms Itamar's PAT Technology to Diagnose Early Cardiovascular Disease 2
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Made exclusively from LactoSorb® Resorbable Copolymer....
... of 25% Hydroxy-Apatite (HA) and 75% Poly-L ... the fixation strength of a titanium interference ... bone. Our wedge design makes it ideal ... increases the healing characteristic of the bone ...
Medicine Products: